Researchers at the University of Washington and the Fred Hutchinson Cancer Center are working on a vaccine to prevent cancer.
Dr. Mary "Nora" Disis and Vivian Goodell say the vaccine would work like immunizations against infectious diseases, the Seattle Post-Intelligencer reported Friday.
The experimental vaccine is being tested in breast cancer patients who have been treated but remain at high risk of relapse.
"Most patients do mount an immune response to cancer," Disis said. "The question is if those immune responses mean anything."
The medical establishment has long dismissed this type of approach, known as immunotherapy, as bordering on quackery.
However, in the 1990s, Disis and her colleagues were among the first to recognize that breast cancer stimulates an immune response.
Copyright 2006 by United Press International
Related stories:
Plants make vaccine for treating type of cancer
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal
Cancer Research.
New study sheds light on how intracellular pathogens trigger the immune system
(PhysOrg.com) -- Disease-causing microbes like the food-borne bacterium Listeria monocytogenes specialize in invading and replicating inside their animal hosts' own cells, making them particularly tricky to defeat. Now, a new study led by biologists at the University of California, Berkeley, has identified a molecular alarm system in which the intracellular pathogen sends out signals that kick the immune response into gear.
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15
Clinical Cancer Research, a journal of the American Association for Cancer Research.
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.
Researchers identify potential new drug candidates to combat 'bird flu'
As the specter of a worldwide outbreak of avian or "bird flu" lingers, health officials recognize that new drugs are desperately needed since some strains of the virus already have developed resistance to the current roster of anti-flu remedies.
Safer, more effective gene therapy
Athens, Ga. – The potential of gene therapy has long been hampered by the risks associated with using viruses as vectors to deliver healthy genes, but a new University of Georgia study helps bring scientists closer to a safe and efficient gene delivery method that doesn't involve viruses.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
(Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.